Lv3
340 积分 2025-11-13 加入
FAK activation drives non-genetic adaptive survival of ALK-rearranged lung cancer under tyrosine kinase inhibitor treatment
3天前
求助中
Targeting internalization, resistance, and response: Insights from ICARUS-LUNG01
19天前
已关闭
Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
2个月前
已完结
EML4-ALK variant-specific genetic interactions shape lung tumorigenesis
3个月前
已完结
Bio‐Orthogonally Labeled Orbitals‐Hybridizing Nanozymes Induce Tissue‐Resident NK Cells for Enhanced Photo‐Immunologic Therapy of Biofilms and Preventing Secondary Infection
3个月前
已完结
PT1.06.01 ERBB2 (HER2) Fusions in Lung Cancer Are Targetable by Anti-HER2 Small Molecules and Antibody-Drug Conjugates
5个月前
已关闭
Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies
5个月前
已完结
Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer
5个月前
已完结
Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations
5个月前
已完结
Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations
5个月前
已完结
皖公网安备34019202002308
